2 / 43
•
Personal financial interests:
Astellas, Atrazeneca, Bayer, BMS, Eusa, Ipsen, Novartis, Pfizer, Sanofi-
Aventis, Roche.
•
Institutional financial interests:
AB Science, Aragon Pharmaceuticals, Arog Pharmaceuticals, INC,
Astellas Pharma., Astrazeneca AB, Aveo Pharmaceuticals INC, Bayer AG, Blueprint Medicines
Corporation, BN Immunotherapeutics INC, Boehringer Ingelheim España, S.A., Bristol-Myers Squibb
International Corporation (BMS), Clovis Oncology, INC, Cougar Biotechnology INC, Deciphera
Pharmaceuticals LLC, Exelixis INC, F. Hoffmann-La Roche LTD, Genentech INC, Glaxosmithkline, SA,
Incyte Corporation, Janssen-Cilag International NV, Karyopharm Therapeutics INC., Laboratoires
Leurquin Mediolanum SAS, Lilly, S.A., Medimmune, Millennium Pharmaceuticals, INC., Nanobiotix SA,
Novartis Farmacéutica, S.A., Pfizer, S.L.U, Puma Biotechnology, INC, Sanofi-Aventis, S.A., SFJ Pharma
LTD. II, Teva Pharma S.L.U.